Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Osteopore Ltd. ( (AU:OSX) ) has provided an announcement.
Osteopore Ltd. announced the cessation of Daniel Ow as a director effective May 29, 2025. The notice details his relevant interests in securities, including multiple tranches of performance rights expiring in 2030. This change in directorship could impact the company’s strategic direction and stakeholder confidence, given the significant role directors play in guiding company operations.
More about Osteopore Ltd.
Osteopore Ltd. operates in the medical technology industry, specializing in the development and commercialization of bioresorbable implants for bone healing. The company’s primary products focus on regenerative solutions that leverage 3D printing technology to support natural bone growth, with a market focus on orthopedic, dental, and craniofacial surgeries.
Average Trading Volume: 2,851,754
Technical Sentiment Signal: Sell
Current Market Cap: A$2.95M
See more insights into OSX stock on TipRanks’ Stock Analysis page.